Boston Trust Walden’s Viatris VTRS Stock Holding History

Boston Trust Walden’s Portfolio VTRS Stock Details VTRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-10,112	Closed	-$189K	–	377
2020 Q4	$189K	Buy	+10,112	New	+$165K	﹤0.01%	372

Other funds holding VTRS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Boston Trust Walden's VTRS Position: Q1 2021 in Review

Boston Trust Walden sold out of Viatris (VTRS) in Q1 2021, closing a stake of 10,112 shares — an estimated $189K sold.

Boston Trust Walden first reported a position in VTRS in Q4 2020 and held it in 1 quarter. The position peaked at $189K in Q4 2020. 1,115 funds tracked by Wall St. Rank hold VTRS as of Q1 2021.

Boston Trust Walden reported no remaining Viatris position as of Q1 2021 after selling out during the quarter.
Boston Trust Walden sold 10,112 Viatris shares in Q1 2021, an estimated $189K.
Boston Trust Walden first reported a position in Viatris in Q4 2020 and held it in 1 quarter.
Boston Trust Walden's Viatris position peaked at $189K in Q4 2020.
1,115 funds tracked by Wall St. Rank held Viatris as of Q1 2021.

Based on Boston Trust Walden's 13F filing for Q1 2021, filed 21 Apr 2021.